Insulin glargine and lixisenatide and Leuprolide and norethindrone
Determining the interaction of Insulin glargine and lixisenatide and Leuprolide and norethindrone and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
Generic Name: leuprolide / norethindrone
Brand name: Lupaneta Pack
Synonyms: Leuprolide and Norethindrone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide-Leuprolide and norethindrone Intramuscular, Oral
- Insulin glargine and lixisenatide-Leuprolide Injection (CPP)
- Insulin glargine and lixisenatide-Leuprolide Injection (Prostate)
- Insulin glargine and lixisenatide-Leuprolide Injection (Women)
- Insulin glargine and lixisenatide-Leuprolide Intramuscular, Subcutaneous, Intradermal, Injection
- Insulin glargine and lixisenatide-Leustatin
- Leuprolide and norethindrone-Insulin glargine and lixisenatide Subcutaneous
- Leuprolide and norethindrone-Insulin glargine, recombinant Subcutaneous
- Leuprolide and norethindrone-Insulin glulisine
- Leuprolide and norethindrone-Insulin Glulisine (Cartridges and Pens)
- Leuprolide and norethindrone-Insulin Glulisine (Vials)
- Leuprolide and norethindrone-Insulin glulisine Subcutaneous